European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: 295, P. 117792 - 117792
Published: May 21, 2025
Language: Английский
European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: 295, P. 117792 - 117792
Published: May 21, 2025
Language: Английский
Nature Communications, Journal Year: 2025, Volume and Issue: 16(1)
Published: May 10, 2025
Fucoidan, a sulfated glycan derived from brown algae, has garnered significant attention for its anticoagulant properties. However, the structural complexity and heterogeneity of naturally extracted fucoidan have hindered comprehensive understanding structure-activity relationship, limiting development fucoidan-based drugs. To address this challenge, we synthesize diverse library 58 distinct fucoidans with multiple contiguous 1,2-cis glycosidic bonds, ranging disaccharides to dodecasaccharides, using highly efficient preactivation-based one-pot glycosylation strategy. This includes compounds various sulfation patterns (2,3-O-di-, 3,4-O-di-, 2,3,4-O-tri-sulfation) encompassing nearly all possible structures. In vitro assays demonstrate that both molecular size degree play crucial roles in potency. Notably, 29, 30, 37, significantly prolong human plasma activated partial thromboplastin time (APTT), comparable effect enoxaparin, without affecting prothrombin (PT) or thrombin (TT). selective inhibition intrinsic coagulation pathway suggests reduced risk bleeding, highlighting therapeutic potential these as safer agents.
Language: Английский
Citations
0European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: 295, P. 117792 - 117792
Published: May 21, 2025
Language: Английский
Citations
0